10-K Decoder · All companies

BioMarin Pharmaceutical Inc.

BMRN · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$3.22B$2.85B+12.9%
Operating income$409M$484M−15.4%
Net income$349M$427M−18.3%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026

$Q3 2026Year earlierChange
Revenue$1.02B$776M+32.0%
Operating income−$82.1M−$46.7M−75.8%
Net income−$123M−$30.7M−300%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was BioMarin's revenue in FY2025?
$3.22B in FY2025 (Fiscal year ended Dec 31, 2025), +12.9% vs $2.85B a year earlier, per its 10-K filed Feb 2026.
Was BioMarin profitable in FY2025?
Yes: net income was $349M and operating income $409M in FY2025.
What was BioMarin's revenue in Q3 2026?
$1.02B (+32.0% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.